坂野 晴彦

最終更新日時: 2019/10/16 11:21:28

印刷する

氏名(漢字／フリガナ／アルファベット表記)
坂野 晴彦／バンノ ハルヒコ／Banno, Haruhiko
所属部署・職名(部局／所属／講座等／職名)
医学部附属病院／臨床研究総合センター／准教授
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
博士（医学） MD, PhD 名古屋大学 Nagoya University
修士（医科学） MMSc ハーバード大学 Harvard Medical School
出身大学院・研究科等
大学名(日本語) 大学名(英語) 研究科名(日本語) 研究科名(英語) 専攻名(日本語) 専攻名(英語) 修了区分
名古屋大学 Nagoya University 大学院医学系研究科博士課程細胞情報医学専攻 Neurology 修了
ハーバード大学 Harvard Medical School 医学部修士課程臨床・橋渡し研究専攻 Clinical and Translational Investigation 修了
出身学校・専攻等
大学名(日本語) 大学名(英語) 学部名(日本語) 学部名(英語) 学科名(日本語) 学科名(英語) 卒業区分
名古屋大学 Nagoya University 医学部医学科 School of Medicine 卒業
researchmap URL
https://researchmap.jp/read0153249
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Hashizume A, Banno H, Katsuno M, Hijikata Y, Yamada S, Inagaki T, Suzuki K, Sobue G Hashizume A, Banno H, Katsuno M, Hijikata Y, Yamada S, Inagaki T, Suzuki K, Sobue G Hashizume A, Banno H, Katsuno M, Hijikata Y, Yamada S, Inagaki T, Suzuki K, Sobue G Quantitative Assessment of Swallowing Dysfunction in Patients with Spinal and Bulbar Muscular Atrophy. Quantitative Assessment of Swallowing Dysfunction in Patients with Spinal and Bulbar Muscular Atrophy. Quantitative Assessment of Swallowing Dysfunction in Patients with Spinal and Bulbar Muscular Atrophy. Internal medicine (Tokyo, Japan), 56, 23, 3159-3165 Internal medicine (Tokyo, Japan), 56, 23, 3159-3165 Internal medicine (Tokyo, Japan), 56, 23, 3159-3165 2017/12 有 公開
Hashizume A, Katsuno M, Suzuki K, Hirakawa A, Hijikata Y, Yamada S, Inagaki T, Banno H, Sobue G Hashizume A, Katsuno M, Suzuki K, Hirakawa A, Hijikata Y, Yamada S, Inagaki T, Banno H, Sobue G Hashizume A, Katsuno M, Suzuki K, Hirakawa A, Hijikata Y, Yamada S, Inagaki T, Banno H, Sobue G Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study. Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study. Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study. Journal of neurology, neurosurgery, and psychiatry, 88, 12, 1026-1032 Journal of neurology, neurosurgery, and psychiatry, 88, 12, 1026-1032 Journal of neurology, neurosurgery, and psychiatry, 88, 12, 1026-1032 2017/12 有 公開
Banno H, Katsuno M, Suzuki K, Tanaka S, Suga N, Hashizume A, Mano T, Araki A, Watanabe H, Fujimoto Y, Yamamoto M, Sobue G Banno H, Katsuno M, Suzuki K, Tanaka S, Suga N, Hashizume A, Mano T, Araki A, Watanabe H, Fujimoto Y, Yamamoto M, Sobue G Banno H, Katsuno M, Suzuki K, Tanaka S, Suga N, Hashizume A, Mano T, Araki A, Watanabe H, Fujimoto Y, Yamamoto M, Sobue G Swallowing markers in spinal and bulbar muscular atrophy. Swallowing markers in spinal and bulbar muscular atrophy. Swallowing markers in spinal and bulbar muscular atrophy. Annals of clinical and translational neurology, 4, 8, 534-543 Annals of clinical and translational neurology, 4, 8, 534-543 Annals of clinical and translational neurology, 4, 8, 534-543 2017/08 有 公開
Nakatsuji H, Araki A, Hashizume A, Hijikata Y, Yamada S, Inagaki T, Suzuki K, Banno H, Suga N, Okada Y, Ohyama M, Nakagawa T, Kishida K, Funahashi T, Shimomura I, Okano H, Katsuno M, Sobue G Nakatsuji H, Araki A, Hashizume A, Hijikata Y, Yamada S, Inagaki T, Suzuki K, Banno H, Suga N, Okada Y, Ohyama M, Nakagawa T, Kishida K, Funahashi T, Shimomura I, Okano H, Katsuno M, Sobue G Nakatsuji H, Araki A, Hashizume A, Hijikata Y, Yamada S, Inagaki T, Suzuki K, Banno H, Suga N, Okada Y, Ohyama M, Nakagawa T, Kishida K, Funahashi T, Shimomura I, Okano H, Katsuno M, Sobue G Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy. Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy. Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy. Journal of neurology, 264, 5, 839-847 Journal of neurology, 264, 5, 839-847 Journal of neurology, 264, 5, 839-847 2017/05 有 公開
Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N Analysis of Participant Withdrawal in Huntington Disease Clinical Trials. Analysis of Participant Withdrawal in Huntington Disease Clinical Trials. Analysis of Participant Withdrawal in Huntington Disease Clinical Trials. Journal of Huntington's disease, 6, 4, 371 Journal of Huntington's disease, 6, 4, 371 Journal of Huntington's disease, 6, 4, 371 2017 有 公開
Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N Analysis of Participant Withdrawal in Huntington Disease Clinical Trials. Analysis of Participant Withdrawal in Huntington Disease Clinical Trials. Analysis of Participant Withdrawal in Huntington Disease Clinical Trials. Journal of Huntington's disease, 6, 2, 149-156 Journal of Huntington's disease, 6, 2, 149-156 Journal of Huntington's disease, 6, 2, 149-156 2017 有 公開
Hijikata Y, Katsuno M, Suzuki K, Hashizume A, Araki A, Yamada S, Inagaki T, Iida M, Noda S, Nakanishi H, Banno H, Mano T, Hirakawa A, Adachi H, Watanabe H, Yamamoto M, Sobue G Hijikata Y, Katsuno M, Suzuki K, Hashizume A, Araki A, Yamada S, Inagaki T, Iida M, Noda S, Nakanishi H, Banno H, Mano T, Hirakawa A, Adachi H, Watanabe H, Yamamoto M, Sobue G Hijikata Y, Katsuno M, Suzuki K, Hashizume A, Araki A, Yamada S, Inagaki T, Iida M, Noda S, Nakanishi H, Banno H, Mano T, Hirakawa A, Adachi H, Watanabe H, Yamamoto M, Sobue G Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy. Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy. Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy. Annals of clinical and translational neurology, 3, 7, 537-546 Annals of clinical and translational neurology, 3, 7, 537-546 Annals of clinical and translational neurology, 3, 7, 537-546 2016/07 有 公開
Yamada S, Hashizume A, Hijikata Y, Inagaki T, Suzuki K, Kondo N, Kawai K, Noda S, Nakanishi H, Banno H, Hirakawa A, Koike H, Halievski K, Jordan CL, Katsuno M, Sobue G Yamada S, Hashizume A, Hijikata Y, Inagaki T, Suzuki K, Kondo N, Kawai K, Noda S, Nakanishi H, Banno H, Hirakawa A, Koike H, Halievski K, Jordan CL, Katsuno M, Sobue G Yamada S, Hashizume A, Hijikata Y, Inagaki T, Suzuki K, Kondo N, Kawai K, Noda S, Nakanishi H, Banno H, Hirakawa A, Koike H, Halievski K, Jordan CL, Katsuno M, Sobue G Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy. Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy. Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy. PloS one, 11, 12, e0168846 PloS one, 11, 12, e0168846 PloS one, 11, 12, e0168846 2016 有 公開
Hashizume A, Katsuno M, Suzuki K, Banno H, Suga N, Mano T, Araki A, Hijikata Y, Grunseich C, Kokkinis A, Hirakawa A, Watanabe H, Yamamoto M, Fischbeck KH, Sobue G Hashizume A, Katsuno M, Suzuki K, Banno H, Suga N, Mano T, Araki A, Hijikata Y, Grunseich C, Kokkinis A, Hirakawa A, Watanabe H, Yamamoto M, Fischbeck KH, Sobue G Hashizume A, Katsuno M, Suzuki K, Banno H, Suga N, Mano T, Araki A, Hijikata Y, Grunseich C, Kokkinis A, Hirakawa A, Watanabe H, Yamamoto M, Fischbeck KH, Sobue G A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study. A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study. A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study. Neuromuscular disorders : NMD, 25, 7, 554-562 Neuromuscular disorders : NMD, 25, 7, 554-562 Neuromuscular disorders : NMD, 25, 7, 554-562 2015/07 有 公開
Suga N, Katsuno M, Koike H, Banno H, Suzuki K, Hashizume A, Mano T, Iijima M, Kawagashira Y, Hirayama M, Nakamura T, Watanabe H, Tanaka F, Sobue G Suga N, Katsuno M, Koike H, Banno H, Suzuki K, Hashizume A, Mano T, Iijima M, Kawagashira Y, Hirayama M, Nakamura T, Watanabe H, Tanaka F, Sobue G Suga N, Katsuno M, Koike H, Banno H, Suzuki K, Hashizume A, Mano T, Iijima M, Kawagashira Y, Hirayama M, Nakamura T, Watanabe H, Tanaka F, Sobue G Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3. Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3. Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3. Neuropathology and applied neurobiology, 40, 5, 628-639 Neuropathology and applied neurobiology, 40, 5, 628-639 Neuropathology and applied neurobiology, 40, 5, 628-639 2014/08 有 公開
Araki A, Katsuno M, Suzuki K, Banno H, Suga N, Hashizume A, Mano T, Hijikata Y, Nakatsuji H, Watanabe H, Yamamoto M, Makiyama T, Ohno S, Fukuyama M, Morimoto S, Horie M, Sobue G Araki A, Katsuno M, Suzuki K, Banno H, Suga N, Hashizume A, Mano T, Hijikata Y, Nakatsuji H, Watanabe H, Yamamoto M, Makiyama T, Ohno S, Fukuyama M, Morimoto S, Horie M, Sobue G Araki A, Katsuno M, Suzuki K, Banno H, Suga N, Hashizume A, Mano T, Hijikata Y, Nakatsuji H, Watanabe H, Yamamoto M, Makiyama T, Ohno S, Fukuyama M, Morimoto S, Horie M, Sobue G Brugada syndrome in spinal and bulbar muscular atrophy. Brugada syndrome in spinal and bulbar muscular atrophy. Brugada syndrome in spinal and bulbar muscular atrophy. Neurology, 82, 20, 1813-1821 Neurology, 82, 20, 1813-1821 Neurology, 82, 20, 1813-1821 2014/05 有 公開
Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, Araki A, Watanabe H, Tanaka S, Yamamoto M, Sobue G Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, Araki A, Watanabe H, Tanaka S, Yamamoto M, Sobue G Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, Araki A, Watanabe H, Tanaka S, Yamamoto M, Sobue G Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy. Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy. Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy. Neurology, 82, 3, 255-262 Neurology, 82, 3, 255-262 Neurology, 82, 3, 255-262 2014/01 有 公開
Katsuno M, Tanaka F, Adachi H, Banno H, Suzuki K, Watanabe H, Sobue G Katsuno M, Tanaka F, Adachi H, Banno H, Suzuki K, Watanabe H, Sobue G Katsuno M, Tanaka F, Adachi H, Banno H, Suzuki K, Watanabe H, Sobue G Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Progress in neurobiology, 99, 3, 246-256 Progress in neurobiology, 99, 3, 246-256 Progress in neurobiology, 99, 3, 246-256 2012/12 有 公開
Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, Tanaka F, Sobue G Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, Tanaka F, Sobue G Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, Tanaka F, Sobue G Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy. Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy. Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy. Muscle & nerve, 46, 5, 692-697 Muscle & nerve, 46, 5, 692-697 Muscle & nerve, 46, 5, 692-697 2012/11 有 公開
Katsuno M, Banno H, Suzuki K, Hashizume A, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Hashizume A, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Hashizume A, Adachi H, Tanaka F, Sobue G [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, translational research; 1) Translational research on neurodegenerative diseases]. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, translational research; 1) Translational research on neurodegenerative diseases]. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, translational research; 1) Translational research on neurodegenerative diseases]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 101, 9, 2533-2538 Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 101, 9, 2533-2538 Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 101, 9, 2533-2538 2012/09 有 公開
Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Mano T, Atsuta N, Oe H, Watanabe H, Tanaka F, Sobue G Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Mano T, Atsuta N, Oe H, Watanabe H, Tanaka F, Sobue G Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Mano T, Atsuta N, Oe H, Watanabe H, Tanaka F, Sobue G Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain : a journal of neurology, 135, Pt 9, 2838-2848 Brain : a journal of neurology, 135, Pt 9, 2838-2848 Brain : a journal of neurology, 135, Pt 9, 2838-2848 2012/09 有 公開
Banno H, Katsuno M, Suzuki K, Tanaka F, Sobue G Banno H, Katsuno M, Suzuki K, Tanaka F, Sobue G Banno H, Katsuno M, Suzuki K, Tanaka F, Sobue G Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). Cell and tissue research, 349, 1, 313-320 Cell and tissue research, 349, 1, 313-320 Cell and tissue research, 349, 1, 313-320 2012/04 有 公開
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy. Archives of neurology, 69, 4, 436-444 Archives of neurology, 69, 4, 436-444 Archives of neurology, 69, 4, 436-444 2012/04 有 公開
Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Tanaka F, Sobue G Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Tanaka F, Sobue G Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Tanaka F, Sobue G Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. Journal of neurology, 259, 4, 712-719 Journal of neurology, 259, 4, 712-719 Journal of neurology, 259, 4, 712-719 2012/04 有 公開
Suzuki K, Banno H, Katsuno M, Adachi H, Tanaka F, Sobue G Suzuki K, Banno H, Katsuno M, Adachi H, Tanaka F, Sobue G Suzuki K, Banno H, Katsuno M, Adachi H, Tanaka F, Sobue G [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)]. [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)]. [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)]. Brain and nerve = Shinkei kenkyu no shinpo, 64, 3, 237-244 Brain and nerve = Shinkei kenkyu no shinpo, 64, 3, 237-244 Brain and nerve = Shinkei kenkyu no shinpo, 64, 3, 237-244 2012/03 有 公開
Hama T, Hirayama M, Hara T, Nakamura T, Atsuta N, Banno H, Suzuki K, Katsuno M, Tanaka F, Sobue G Hama T, Hirayama M, Hara T, Nakamura T, Atsuta N, Banno H, Suzuki K, Katsuno M, Tanaka F, Sobue G Hama T, Hirayama M, Hara T, Nakamura T, Atsuta N, Banno H, Suzuki K, Katsuno M, Tanaka F, Sobue G Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials. Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials. Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials. Muscle & nerve, 45, 2, 169-174 Muscle & nerve, 45, 2, 169-174 Muscle & nerve, 45, 2, 169-174 2012/02 有 公開
Tanaka F, Katsuno M, Banno H, Suzuki K, Adachi H, Sobue G Tanaka F, Katsuno M, Banno H, Suzuki K, Adachi H, Sobue G Tanaka F, Katsuno M, Banno H, Suzuki K, Adachi H, Sobue G Current status of treatment of spinal and bulbar muscular atrophy. Current status of treatment of spinal and bulbar muscular atrophy. Current status of treatment of spinal and bulbar muscular atrophy. Neural plasticity, 2012, 369284 Neural plasticity, 2012, 369284 Neural plasticity, 2012, 369284 2012 有 公開
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G [TGF-beta signaling in neurodegenerative diseases]. [TGF-beta signaling in neurodegenerative diseases]. [TGF-beta signaling in neurodegenerative diseases]. Rinsho shinkeigaku = Clinical neurology, 51, 11, 982-985 Rinsho shinkeigaku = Clinical neurology, 51, 11, 982-985 Rinsho shinkeigaku = Clinical neurology, 51, 11, 982-985 2011/11 有 公開
Banno H, Katsuno M, Suzuki K, Sobue G Banno H, Katsuno M, Suzuki K, Sobue G Banno H, Katsuno M, Suzuki K, Sobue G Dutasteride for spinal and bulbar muscular atrophy. Dutasteride for spinal and bulbar muscular atrophy. Dutasteride for spinal and bulbar muscular atrophy. Lancet neurology, 10, 2, 113-115 Lancet neurology, 10, 2, 113-115 Lancet neurology, 10, 2, 113-115 2011/02 有 公開
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I, Sasaki H, Aoki M, Morita M, Nakano I, Kanai K, Ito S, Ishikawa K, Mizusawa H, Yamamoto T, Tsuji S, Hasegawa K, Shimohata T, Nishizawa M, Miyajima H, Kanda F, Watanabe Y, Nakashima K, Tsujino A, Yamashita T, Uchino M, Fujimoto Y, Tanaka F, Sobue G, Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I, Sasaki H, Aoki M, Morita M, Nakano I, Kanai K, Ito S, Ishikawa K, Mizusawa H, Yamamoto T, Tsuji S, Hasegawa K, Shimohata T, Nishizawa M, Miyajima H, Kanda F, Watanabe Y, Nakashima K, Tsujino A, Yamashita T, Uchino M, Fujimoto Y, Tanaka F, Sobue G, Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I, Sasaki H, Aoki M, Morita M, Nakano I, Kanai K, Ito S, Ishikawa K, Mizusawa H, Yamamoto T, Tsuji S, Hasegawa K, Shimohata T, Nishizawa M, Miyajima H, Kanda F, Watanabe Y, Nakashima K, Tsujino A, Yamashita T, Uchino M, Fujimoto Y, Tanaka F, Sobue G, Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet neurology, 9, 9, 875-884 Lancet neurology, 9, 9, 875-884 Lancet neurology, 9, 9, 875-884 2010/09 有 公開
Suzuki K, Katsuno M, Banno H, Takeuchi Y, Kawashima M, Suga N, Hashizume A, Hama T, Uchida K, Yamashita F, Nakamura T, Hirayama M, Tanaka F, Sobue G Suzuki K, Katsuno M, Banno H, Takeuchi Y, Kawashima M, Suga N, Hashizume A, Hama T, Uchida K, Yamashita F, Nakamura T, Hirayama M, Tanaka F, Sobue G Suzuki K, Katsuno M, Banno H, Takeuchi Y, Kawashima M, Suga N, Hashizume A, Hama T, Uchida K, Yamashita F, Nakamura T, Hirayama M, Tanaka F, Sobue G The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. Journal of neurology, neurosurgery, and psychiatry, 81, 5, 567-571 Journal of neurology, neurosurgery, and psychiatry, 81, 5, 567-571 Journal of neurology, neurosurgery, and psychiatry, 81, 5, 567-571 2010/05 有 公開
Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, Kondo N, Mizoguchi H, Nitta A, Yamada K, Banno H, Suzuki K, Tanaka F, Sobue G Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, Kondo N, Mizoguchi H, Nitta A, Yamada K, Banno H, Suzuki K, Tanaka F, Sobue G Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, Kondo N, Mizoguchi H, Nitta A, Yamada K, Banno H, Suzuki K, Tanaka F, Sobue G Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. The Journal of neuroscience : the official journal of the Society for Neuroscience, 30, 16, 5702-5712 The Journal of neuroscience : the official journal of the Society for Neuroscience, 30, 16, 5702-5712 The Journal of neuroscience : the official journal of the Society for Neuroscience, 30, 16, 5702-5712 2010/04 有 公開
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). Advances in experimental medicine and biology, 685, 64-74 Advances in experimental medicine and biology, 685, 64-74 Advances in experimental medicine and biology, 685, 64-74 2010 有 公開
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G [Molecular-targeted therapies for spinal and bulbar muscular atrophy]. [Molecular-targeted therapies for spinal and bulbar muscular atrophy]. [Molecular-targeted therapies for spinal and bulbar muscular atrophy]. Rinsho shinkeigaku = Clinical neurology, 49, 11, 917-920 Rinsho shinkeigaku = Clinical neurology, 49, 11, 917-920 Rinsho shinkeigaku = Clinical neurology, 49, 11, 917-920 2009/11 有 公開
Banno H, Katsuno M, Suzuki K, Iguchi Y, Adachi H, Tanaka F, Sobue G Banno H, Katsuno M, Suzuki K, Iguchi Y, Adachi H, Tanaka F, Sobue G Banno H, Katsuno M, Suzuki K, Iguchi Y, Adachi H, Tanaka F, Sobue G [Molecular-targeted therapy for motor neuron disease]. [Molecular-targeted therapy for motor neuron disease]. [Molecular-targeted therapy for motor neuron disease]. Brain and nerve = Shinkei kenkyu no shinpo, 61, 8, 891-900 Brain and nerve = Shinkei kenkyu no shinpo, 61, 8, 891-900 Brain and nerve = Shinkei kenkyu no shinpo, 61, 8, 891-900 2009/08 有 公開
Banno H, Katsuno M, Suzuki K, Tanaka F, Sobue G Banno H, Katsuno M, Suzuki K, Tanaka F, Sobue G Banno H, Katsuno M, Suzuki K, Tanaka F, Sobue G Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. International journal of molecular sciences, 10, 3, 1000-1012 International journal of molecular sciences, 10, 3, 1000-1012 International journal of molecular sciences, 10, 3, 1000-1012 2009/03 有 公開
Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, Sobue G Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, Sobue G Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, Sobue G Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Annals of neurology, 65, 2, 140-150 Annals of neurology, 65, 2, 140-150 Annals of neurology, 65, 2, 140-150 2009/02 有 公開
Takeuchi Y, Katsuno M, Banno H, Suzuki K, Kawashima M, Atsuta N, Ito M, Watanabe H, Tanaka F, Sobue G Takeuchi Y, Katsuno M, Banno H, Suzuki K, Kawashima M, Atsuta N, Ito M, Watanabe H, Tanaka F, Sobue G Takeuchi Y, Katsuno M, Banno H, Suzuki K, Kawashima M, Atsuta N, Ito M, Watanabe H, Tanaka F, Sobue G Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle & nerve, 38, 2, 964-971 Muscle & nerve, 38, 2, 964-971 Muscle & nerve, 38, 2, 964-971 2008/08 有 公開
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Tanaka F, Adachi H, Sobue G Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Tanaka F, Adachi H, Sobue G Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Tanaka F, Adachi H, Sobue G Molecular genetics and biomarkers of polyglutamine diseases. Molecular genetics and biomarkers of polyglutamine diseases. Molecular genetics and biomarkers of polyglutamine diseases. Current molecular medicine, 8, 3, 221-234 Current molecular medicine, 8, 3, 221-234 Current molecular medicine, 8, 3, 221-234 2008/05 有 公開
Suzuki K, Katsuno M, Banno H, Takeuchi Y, Atsuta N, Ito M, Watanabe H, Yamashita F, Hori N, Nakamura T, Hirayama M, Tanaka F, Sobue G Suzuki K, Katsuno M, Banno H, Takeuchi Y, Atsuta N, Ito M, Watanabe H, Yamashita F, Hori N, Nakamura T, Hirayama M, Tanaka F, Sobue G Suzuki K, Katsuno M, Banno H, Takeuchi Y, Atsuta N, Ito M, Watanabe H, Yamashita F, Hori N, Nakamura T, Hirayama M, Tanaka F, Sobue G CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain : a journal of neurology, 131, Pt 1, 229-239 Brain : a journal of neurology, 131, Pt 1, 229-239 Brain : a journal of neurology, 131, Pt 1, 229-239 2008/01 有 公開
Okamoto K, Yamazaki T, Banno H, Sobue G, Yoshida M, Takatama M Okamoto K, Yamazaki T, Banno H, Sobue G, Yoshida M, Takatama M Okamoto K, Yamazaki T, Banno H, Sobue G, Yoshida M, Takatama M Neuropathological studies of patients with possible non-herpetic acute limbic encephalitis and so-called acute juvenile female non-herpetic encephalitis. Neuropathological studies of patients with possible non-herpetic acute limbic encephalitis and so-called acute juvenile female non-herpetic encephalitis. Neuropathological studies of patients with possible non-herpetic acute limbic encephalitis and so-called acute juvenile female non-herpetic encephalitis. Internal medicine (Tokyo, Japan), 47, 4, 231-236 Internal medicine (Tokyo, Japan), 47, 4, 231-236 Internal medicine (Tokyo, Japan), 47, 4, 231-236 2008 有 公開
Yoshida K, Okano T, Hoshi K, Yahikozawa H, Suzuki K, Banno H, Tamura T, Sobue G, Ikeda S Yoshida K, Okano T, Hoshi K, Yahikozawa H, Suzuki K, Banno H, Tamura T, Sobue G, Ikeda S Yoshida K, Okano T, Hoshi K, Yahikozawa H, Suzuki K, Banno H, Tamura T, Sobue G, Ikeda S Congenital fibrosis of the extraocular muscles (CFEOM) syndrome associated with progressive cerebellar ataxia. Congenital fibrosis of the extraocular muscles (CFEOM) syndrome associated with progressive cerebellar ataxia. Congenital fibrosis of the extraocular muscles (CFEOM) syndrome associated with progressive cerebellar ataxia. American journal of medical genetics. Part A, 143A, 13, 1494-1501 American journal of medical genetics. Part A, 143A, 13, 1494-1501 American journal of medical genetics. Part A, 143A, 13, 1494-1501 2007/07 有 公開
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Sobue G Katsuno M, Banno H, Suzuki K, Takeuchi Y, Sobue G Katsuno M, Banno H, Suzuki K, Takeuchi Y, Sobue G [Paradigm shift in clinical trials for neurodegenerative diseases]. [Paradigm shift in clinical trials for neurodegenerative diseases]. [Paradigm shift in clinical trials for neurodegenerative diseases]. Brain and nerve = Shinkei kenkyu no shinpo, 59, 4, 367-374 Brain and nerve = Shinkei kenkyu no shinpo, 59, 4, 367-374 Brain and nerve = Shinkei kenkyu no shinpo, 59, 4, 367-374 2007/04 有 公開
Katsuno M, Adachi H, Minamiyama M, Waza M, Tokui K, Banno H, Suzuki K, Onoda Y, Tanaka F, Doyu M, Sobue G Katsuno M, Adachi H, Minamiyama M, Waza M, Tokui K, Banno H, Suzuki K, Onoda Y, Tanaka F, Doyu M, Sobue G Katsuno M, Adachi H, Minamiyama M, Waza M, Tokui K, Banno H, Suzuki K, Onoda Y, Tanaka F, Doyu M, Sobue G Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. The Journal of neuroscience : the official journal of the Society for Neuroscience, 26, 47, 12106-12117 The Journal of neuroscience : the official journal of the Society for Neuroscience, 26, 47, 12106-12117 The Journal of neuroscience : the official journal of the Society for Neuroscience, 26, 47, 12106-12117 2006/11 有 公開
Katsuno M, Adachi H, Waza M, Banno H, Suzuki K, Tanaka F, Doyu M, Sobue G Katsuno M, Adachi H, Waza M, Banno H, Suzuki K, Tanaka F, Doyu M, Sobue G Katsuno M, Adachi H, Waza M, Banno H, Suzuki K, Tanaka F, Doyu M, Sobue G Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Experimental neurology, 200, 1, 8-18 Experimental neurology, 200, 1, 8-18 Experimental neurology, 200, 1, 8-18 2006/07 有 公開
Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, Tanaka F, Tamakoshi A, Sobue G Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, Tanaka F, Tamakoshi A, Sobue G Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, Tanaka F, Tamakoshi A, Sobue G Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain : a journal of neurology, 129, Pt 6, 1446-1455 Brain : a journal of neurology, 129, Pt 6, 1446-1455 Brain : a journal of neurology, 129, Pt 6, 1446-1455 2006/06 有 公開
Banno H, Adachi H, Katsuno M, Suzuki K, Atsuta N, Watanabe H, Tanaka F, Doyu M, Sobue G Banno H, Adachi H, Katsuno M, Suzuki K, Atsuta N, Watanabe H, Tanaka F, Doyu M, Sobue G Banno H, Adachi H, Katsuno M, Suzuki K, Atsuta N, Watanabe H, Tanaka F, Doyu M, Sobue G Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Annals of neurology, 59, 3, 520-526 Annals of neurology, 59, 3, 520-526 Annals of neurology, 59, 3, 520-526 2006/03 有 公開

  • <<
  • >>
  • 表示
タイトル言語:

前のページへ戻る

このページのTOPへ